Literature DB >> 22553579

β-catenin expression in rat neovascularized cornea after alkali burn.

Li Wang1, Ming-Chang Zhang, Ying Zhang, Zhi He, Li Zhang, Shi-Yi Xiao.   

Abstract

AIM: To investigate the expression of β-catenin in cornea after alkali burn and explore its role in cornea neovascularization (CNV).
METHODS: CNV model was established by putting filter paper with the size of 3.0mm in diameter immersed in 1mol/L NaOH solution on the left cornea of rat for 20 seconds. Twenty-five Sprague Dawley rats were randomly divided into 5 groups: post-operation 1-, 4-, 7-, 14- and 21-day groups while the right eyes as normal control group. The expression level of β-catenin protein, mRNA and VEGF were determined at the 1(st), 4(th), 7(th), 14(th) and 21(st) day following the establishment of model by RT-PCR and immunohistochemical technique.
RESULTS: No expression of β-catenin immunoreactivity was detected in normal cornea. The expressions of β-catenin and VEGF both reached the peak at the 4(th) and 7(th) day and gradually decreased to near baseline 21 days later. Alteration of β-catenin and VEGF levels showed a significant positive correlation (r=0.855, P<0.05).
CONCLUSION: The levels of β-catenin are markedly related to inflammatory CNV in rat cornea after alkali burn.

Entities:  

Keywords:  VEGF; cornea alkali burn; corneal neovascularization; β-catenin

Year:  2010        PMID: 22553579      PMCID: PMC3340742          DOI: 10.3980/j.issn.2222-3959.2010.04.06

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  7 in total

1.  Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis.

Authors:  M Takahashi; M Mutoh; T Kawamori; T Sugimura; K Wakabayashi
Journal:  Carcinogenesis       Date:  2000-07       Impact factor: 4.944

2.  Beta-catenin overexpression augments angiogenesis and skeletal muscle regeneration through dual mechanism of vascular endothelial growth factor-mediated endothelial cell proliferation and progenitor cell mobilization.

Authors:  Kwang-il Kim; Hyun-Ju Cho; Joo-Yong Hahn; Tae-Youn Kim; Kyung-Woo Park; Bon-Kwon Koo; Chan Soo Shin; Cheol-Ho Kim; Byung-Heeh Oh; Myoung-Mook Lee; Young-Bae Park; Hyo-Soo Kim
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-10-27       Impact factor: 8.311

Review 3.  Catenins, Wnt signaling and cancer.

Authors:  N Barker; H Clevers
Journal:  Bioessays       Date:  2000-11       Impact factor: 4.345

4.  Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia.

Authors:  X Zhang; J P Gaspard; D C Chung
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

5.  Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors.

Authors:  R Masood; J Cai; T Zheng; D L Smith; D R Hinton; P S Gill
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

6.  Role of beta-catenin in hepatocarcinogenesis of rats.

Authors:  Qi-Ming Wang; Kai-Ming Yang; Hong-Ying Zhou; Zhen-Hai Yu; Xiao Li; Hui-Jun Yang
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2006-02

7.  Angiogenesis effects of nerve growth factor (NGF) on rat corneas.

Authors:  K Seo; J Choi; M Park; C Rhee
Journal:  J Vet Sci       Date:  2001-08       Impact factor: 1.672

  7 in total
  2 in total

1.  Antifibrotic Actions of Peroxisome Proliferator-Activated Receptor γ Ligands in Corneal Fibroblasts Are Mediated by β-Catenin-Regulated Pathways.

Authors:  Kye-Im Jeon; Richard P Phipps; Patricia J Sime; Krystel R Huxlin
Journal:  Am J Pathol       Date:  2017-06-10       Impact factor: 4.307

2.  Nanoparticle-mediated expression of a Wnt pathway inhibitor ameliorates ocular neovascularization.

Authors:  Zhongxiao Wang; Rui Cheng; Kyungwon Lee; Puneet Tyagi; Lexi Ding; Uday B Kompella; Jing Chen; Xun Xu; Jian-Xing Ma
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-02-05       Impact factor: 8.311

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.